Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
2
Added to
15
Trimmed
4
Exited
5
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $17.40B across 118 positions in their Q1 2022 SEC 13F filing (period ending 2022-03-31). The top 10 positions account for 85.0% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | $6.76B | 38.83% | +0.0% |
| 2 | INCYIncyte Corporation | $2.87B | 16.50% | +7.5% |
| 3 | ONCBeiGene, Ltd. | $2.20B | 12.65% | - |
| 4 | ACADACADIA Pharmaceuticals Inc. | $1.02B | 5.83% | - |
| 5 | BMRNBioMarin Pharmaceutical Inc. | $587.54M | 3.38% | - |
| 6 | ASNDUSDAscendis Pharma A/S | $533.00M | 3.06% | - |
| 7 | ARGXargenx SE | $353.01M | 2.03% | - |
| 8 | BCRXBioCryst Pharmaceuticals, Inc. | $206.68M | 1.19% | - |
| 9 | MDGLMadrigal Pharmaceuticals, Inc. | $147.10M | 0.85% | - |
| 10 | KODKodiak Sciences Inc. | $122.99M | 0.71% | +8.5% |
| Stock | Value | Shares |
|---|---|---|
| VERAVera Therapeutics, Inc. | $7.83M | 333,333 |
| EPZMEUREpizyme, Inc. | $1.15M | 1,000,000 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.